Cargando…
Serum butyrylcholinesterase as a marker of COVID-19 mortality: Results of the monocentric prospective observational study
The COVID-19 pandemic represents an excessive burden on health care systems worldwide and the number of patients who require special care in the clinical setting is often hard to predict. Consequently, there is an unmet need for a reliable biomarker that could predict clinical outcomes of high-risk...
Autores principales: | Markuskova, Lucia, Javorova Rihova, Zuzana, Fazekas, Tomas, Martinkovicova, Anna, Havrisko, Martina, Dingova, Dominika, Solavova, Maria, Rabarova, Daria, Hrabovska, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195767/ https://www.ncbi.nlm.nih.gov/pubmed/37209860 http://dx.doi.org/10.1016/j.cbi.2023.110557 |
Ejemplares similares
-
Micafungin Is an Efficient Treatment of Multi Drug-Resistant Candida glabrata Urosepsis: A Case Report
por: Javorova Rihova, Zuzana, et al.
Publicado: (2021) -
Butyrylcholinesterase–Protein Interactions in Human Serum
por: Jasiecki, Jacek, et al.
Publicado: (2021) -
Critically Ill COVID-19 Patients Show Reduced Point of Care-Measured Butyrylcholinesterase Activity—A Prospective, Monocentric Observational Study
por: Espeter, Florian, et al.
Publicado: (2022) -
Butyrylcholinesterase as a prognostic marker: a review of the literature
por: Santarpia, Lidia, et al.
Publicado: (2012) -
New Insights into Butyrylcholinesterase Activity Assay: Serum Dilution Factor as a Crucial Parameter
por: Jońca, Joanna, et al.
Publicado: (2015)